Association of interleukin-1β -511 C/T polymorphism with tobacco-associated cancer in northeast India: A study on oral and gastric cancer

Cancer Genetics

Volumn 207, Issue 1-2, 2014, Pages 1-11

  Lakhanpal, Meena ^a   Yadav, Dhirendra Singh ^a   Devi, Thoudam Regina ^a   Singh, Laishram Chandreshwor ^a   Singh, Khangembam Jitenkumar ^a   Latha, Santhi P ^a   Chauhan, Pradeep Singh ^a   Verma, Yogesh ^b   Zomavia, Eric ^c   Sharma, Jagannath ^d   Chandra Kataki, Amal ^d   Saxena, Sunita ^a   Kapur, Sujala ^a  

^a INDIAN COUNCIL OF MEDICAL RESEARCH   (India)

^b Sir TNM Hospital   (India)

^c CIVIL HOSPITAL   (India)

^d Civil Hospital ^*  (India)

Author keywords

Cancer; IL 1 ; Northeast India; Polymorphism; Tobacco

Indexed keywords

INTERLEUKIN 1BETA;

ADULT; ALCOHOL CONSUMPTION; ALLELE; ARTICLE; BETEL NUT; CARCINOGENESIS; CASE CONTROL STUDY; CONTROLLED STUDY; CYTOKINE PRODUCTION; DNA ISOLATION; ENVIRONMENTAL FACTOR; FEMALE; GENETIC MODEL; GENETIC POLYMORPHISM; GENOTYPE; HUMAN; INDIA; INHERITANCE; MAJOR CLINICAL STUDY; MALE; MIDDLE AGED; MOUTH CANCER; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; RESTRICTION FRAGMENT LENGTH POLYMORPHISM; RISK FACTOR; RISK REDUCTION; SMOKING; STOMACH CANCER; TOBACCO CONSUMPTION;

NICOTIANA TABACUM; PIPER BETEL;

CANCER; IL-1Β; NORTHEAST INDIA; POLYMORPHISM; TOBACCO;

ADULT; AGED; ALCOHOL DRINKING; ALLELES; ARECA; CASE-CONTROL STUDIES; FEMALE; GENETIC PREDISPOSITION TO DISEASE; GENOTYPE; HUMANS; INDIA; INTERLEUKIN-1BETA; MALE; MIDDLE AGED; MOUTH NEOPLASMS; ODDS RATIO; POLYMORPHISM, RESTRICTION FRAGMENT LENGTH; POLYMORPHISM, SINGLE NUCLEOTIDE; RISK FACTORS; SEQUENCE ANALYSIS, DNA; SMOKING; STOMACH NEOPLASMS; TOBACCO; TOBACCO, SMOKELESS;

EID: 84896492568     PISSN: 22107762     EISSN: 22107770     Source Type: Journal    
DOI: 10.1016/j.cancergen.2014.01.002     Document Type: Article

References (51)

1. Hildebrand F., Pape H.C., Krettek C. The importance of cytokines in the posttraumatic inflammatory reaction. Unfallchirurg 2005, 108:793-794. 796-803.
2. Dinarello C.A. Biologic basis for interleukin-1 in disease. Blood 1996, 87:2095-2147.
3. Apte R.N., Krelin Y., Song X., et al. Effects of micro-environment- and malignant cell-derived interleukin-1 in carcinogenesis, tumour invasiveness and tumour-host interactions. Eur J Cancer 2006, 42:751-759.
4. Elaraj D.M., Weinreich D.M., Varghese S., et al. The role of interleukin 1 in growth and metastasis of human cancer xenografts. Clin Cancer Res 2006, 12:1088-1096.
5. Chen Z., Malhotra P.S., Thomas G.R., et al. Expression of proinflammatory and proangiogenic cytokines in patients with head and neck cancer. Clin Cancer Res 1999, 5:1369-1379.
6. Gemma A., Takenaka K., Hosoya Y., Matuda K., et al. Altered expression of several genes in highly metastatic subpopulations of a human pulmonary adenocarcinoma cell line. Eur J Cancer 2001, 37:1554-1561.
7. Muerkoster S., Wegehenkel K., Arlt A., et al. Tumor stroma interactions induce chemoresistance in pancreatic ductal carcinoma cells involving increased secretion and paracrine effects of nitric oxide and interleukin-1beta. Cancer Res 2004, 64:1331-1337.
8. Stefani A.L., Basso D., Panozzo M.P., et al. Cytokines modulate MIA PaCa 2 and CAPAN-1 adhesion to extracellular matrix proteins. Pancreas 1999, 19:362-369.
9. Ten Kate M., Hofland L.J., van Koetsveld P.M., et al. Pro-inflammatory cytokines affect pancreatic carcinoma cell. Endothelial cell interactions. JOP 2006, 7:454-464.
10. Angst E., Reber H.A., Hines O.J., et al. Mononuclear cell-derived interleukin-1 beta confers chemoresistance in pancreatic cancer cells by upregulation of cyclooxygenase-2. Surgery 2008, 144:57-65.
11. Xu J., Yin Z., Cao S., et al. Systematic Review and Meta-Analysis on the Association between IL-1B Polymorphisms and Cancer Risk. PLoS One 2013, 8:e63654.
12. Speirs V., Kerin M.J., Newton C.J., et al. Evidence for transcriptional activation of ERalpha by IL-1beta in breast cancer cells. Int J Oncol 1999, 15:1251-1254.
13. Xing F, Kobayashi A, Okuda H, etal. Reactive astrocytes promote the metastatic growth of breast cancer stem-like cells by activating Notch signalling in brain. EMBO Mol Med;5:384-396.
14. El-Omar E.M., Carrington M., Chow W.H., et al. Interleukin-1 polymorphisms associated with increased risk of gastric cancer. Nature 2000, 404:398-402.
15. Bidwell J.L., Keen L., Gallagher G., et al. Cytokine gene polymorphism in human disease: on-line databases. Genes Immun 1999, 1:3-19.
16. Lind H., Zienolddiny S., Ryberg D., et al. Interleukin 1 receptor antagonist gene polymorphism and risk of lung cancer: a possible interaction with polymorphisms in the interleukin 1 beta gene. Lung Cancer 2005, 50:285-290.
17. Kang S., Kim J.W., Park N.H., et al. Interleukin-1 beta-511 polymorphism and risk of cervical cancer. JKorean Med Sci 2007, 22:110-113.
18. Upadhyay R., Jain M., Kumar S., et al. Potential influence of interleukin-1 haplotype IL-1 beta-511*T-IL-1RN*1 in conferring low risk to middle third location of esophageal cancer: a case-control study. Hum Immunol 2008, 69:179-186.
19. Liu J., Zhai X., Jin G., et al. Functional variants in the promoter of interleukin-1beta are associated with an increased risk of breast cancer: a case-control analysis in a Chinese population. Int J Cancer 2006, 118:2554-2558.
20. Kato S., Onda M., Yamada S., et al. Association of the interleukin-1 beta genetic polymorphism and gastric cancer risk in Japanese. JGastroenterol 2001, 36:696-699.
21. Chang Y.W., Jang J.Y., Kim N.H., et al. Interleukin-1B (IL-1B) polymorphisms and gastric mucosal levels of IL-1beta cytokine in Korean patients with gastric cancer. Int J Cancer 2005, 114:465-471.
22. Wex T., Leodolter A., Bornschein J., et al. Interleukin 1 beta (IL1B) gene polymorphisms are not associated with gastric carcinogenesis in Germany. Anticancer Res 2010, 30:505-511.
23. Mudur G. India has some of the highest cancer rates in the world. BMJ 2005, 330:215.
24. Kuschner W.G., D'Alessandro A., Wong H., Blanc P.D. Dose-dependent cigarette smoking-related inflammatory responses in healthy adults. Eur Respir J 1996, 9:1989-1994.
25. Hart K., Haugen A., Zienolddiny S. Allele-specific induction of IL1B -31T/C promoter polymorphism by lung carcinogens. Mutat Res 2008, 30(656):14-18.
26. Guidelines for controlling and monitoring the tobacco epidemic 1998, World Health Organization, WHO, Geneva, Switzerland.
27. Camargo J.F., Correa P.A., Castiblanco J., Anaya J.M. Interleukin-1beta polymorphisms in Colombian patients with autoimmune rheumatic diseases. Genes Immun 2004, 5:609-614.
28. Wu K.S., Zhou X., Zheng F., et al. Influence of interleukin-1 betagenetic polymorphism, smoking and alcohol drinking on the risk of non-small cell lung cancer. Clin Chim Acta 2010, 411:1441-1446.
29. Asada M., Yasuda H., Ebihara S., et al. Interleukin-1beta gene polymorphisms associated with risk of lung cancer in Japanese. Lung Cancer 2006, 54:261-263.
30. Hirankarn N., Kimkong I., Kummee P., et al. Interleukin-1beta gene polymorphism associated with hepatocellular carcinoma in hepatitis B virus infection. World J Gastroenterol 2006, 12:776-779.
31. Zeng Z.R., Hu P.J., Hu S., et al. Association of interleukin 1B gene polymorphism and gastric cancers in high and low prevalence regions in China. Gut 2003, 52:1684-1689.
32. Ruzzo A., Graziano F., Pizzagalli F., et al. Interleukin 1B gene (IL-1B) and interleukin 1 receptor antagonist gene (IL-1RN) polymorphisms in Helicobacter pylori-negative gastric cancer of intestinal and diffuse histotype. Ann Oncol 2005, 16:887-892.
33. Sanabria-Salas M.C., Umaa Y.A.U., Serrano M.L., et al. Sex-specific association between IL-1B-511 polymorphism and colorectal cancer in Colombian populations. Cancer Research 2011, 71. abstract B8.
34. Zhu Y., Xu Y., Wei Y., et al. Association of IL-1B gene polymorphisms with nasopharyngeal carcinoma in a Chinese population. Clin Oncol (R Coll Radiol) 2008, 20:207-211.
35. Singh H., Sachan R., Goel H., Mittal B. Genetic variants of interleukin-1RN and interleukin-1beta genes and risk of cervical cancer. BJOG 2008, 115:633-638.
36. Hefler L.A., Ludwig E., Lebrecht A., et al. Polymorphisms of the interleukin-1 gene cluster and ovarian cancer. JSoc Gynecol Investig 2002, 9:386-390.
37. Perri F., Piepoli A., Bonvicini C., et al. Cytokine gene polymorphisms in gastric cancer patients from two Italian areas at high and low cancer prevalence. Cytokine 2005, 30:293-302.
38. Jin L., Jia Y., Zhang B., et al. Association analysis of a polymorphism of interleukin 1 beta (IL-1 beta) gene with temporal lobeepilepsy in a Chinese population. Epilepsia 2003, 44:1306-1309.
39. Kumar S., Kumar A., Dixit V.K. Evidences showing association of interleukin-1B polymorphisms with increased risk of gastric cancer in an Indian population. Biochem Biophys Res Commun 2009, 387:456-460.
40. Auron P.E., Webb A.C. Interleukin-1: a gene expression system regulated at multiple levels. Eur Cytokine Netw 1994, 5:573-592.
41. Camargo M.C., Mera R., Correa P., et al. Interleukin-1beta and interleukin-1 receptor antagonist gene polymorphisms and gastric cancer: a meta-analysis. Cancer Epidemiol Biomarkers Prev 2006, 15:1674-1687.
42. Zhang W.H., Wang X.L., Zhou J., et al. Association of interleukin-1B (IL-1B) gene polymorphisms with risk of gastric cancer in Chinese population. Cytokine 2005, 30:378-381.
43. Glas J., Torok H.P., Schneider A., et al. Allele 2 of the interleukin-1 receptor antagonist gene is associated with early gastric cancer. JClin Oncol 2004, 22:4746-4752.
44. Lee K.A., Ki C.S., Kim H.J., et al. Novel interleukin 1beta polymorphism increased the risk of gastric cancer in a Korean population. JGastroenterol 2004, 39:429-433.
45. He B.S., Pan Y.Q., Xu Y.F., et al. Polymorphisms in interleukin-1B (IL-1B) and interleukin 1 receptor antagonist (IL-1RN) genes associate with gastric cancer risk in the Chinese population. Dig Dis Sci 2011, 56:2017-2023.
46. Machado J.C., Pharoah P., Sousa S., et al. Interleukin 1B and interleukin 1RN polymorphisms are associated with increased risk of gastric carcinoma. Gastroenterology 2001, 121:823-829.
47. Peleteiro B., Lunet N., Carrilho C., et al. Association between cytokine gene polymorphisms and gastric precancerous lesions: systematic review and meta-analysis. Cancer Epidemiol Biomarkers Prev 2010, 19:762-776.
48. Jablonska E., Piotrowski L., Grabowska Z. Serum levels of IL-1b, IL-6, TNF-a, sTNF-RI and CRP in patients with oral cavity cancer. Pathol Oncol Res 1997, 3:126-129.
49. Tsai C.C., Chen C.C., Lin C.C., et al. Interleukin-1 beta in oral submucous fibrosis, verrucous hyperplasia and squamous cell carcinoma tissues. JMed Sci 1999, 15:513-519.
50. Vairaktaris E., Serefoglou Z., Yapijakis C., et al. The interleukin-1 beta gene polymorphism +3953 C/T is not associated with risk for oral cancer. Anticancer Res 2007, 27:3981-3986.
51. Wen C.P., Tsai M.K., Chung W.S., et al. Cancer risks from betel quid chewing beyond oral cancer: a multiple-site carcinogen when acting with smoking. Cancer Causes Control 2010, 21:1427-1435.